$RPRX..$6.23.. Brean Capital Maintains Buy On Repros, $41 PT. -This target price is overly ambitious and Brean is one of the "boutique" firms that I don't follow nor care to. It's comical and this analyst does not have a good track record. When will it get to $41 share Aschoff? This is when investors need to be wary of analysts calling for outrageous stock price stocks they follow when there is nothing there.